The department of radiology at the University of Rochester School of Medicine and Dentistry will hold its fifth annual PACS Conference in San Antonio, TX, at the Westin Riverwalk Hotel from March 9 to 12. The conference offers up to 29.50 category 1 credits.
The four-day conference, The Expanding Integrated Digital Healthcare Enterprise, will include sessions on fundamentals, reengineering workflow, and clinical applications such as the electronic health record and the healthcare enterprise archive.
The event is geared toward physicians who want to implement or enhance a digital environment in their practice, administrators who want to understand the operational and economic benefits of a digital information environment, information technology personnel who need insights into providing an accessible and secure environment, and vendors who must understand the clinical and operational requirements for their innovative offerings.
More than 50 companies representing all aspects of the digital healthcare industry will be on hand to display their clinical applications, visualization systems, storage solutions, and other products and services that enhance workflow and productivity.
According to Dr. Edward M. Smith, a professor of radiology and the conference director, PACS 2005 will stress two factors:
- All clinical departments should participate in the digital environment.
- An integrated enterprise-wide storage solution under the management of information technology officers will meet the emerging requirements for compliance with statutory mandates and availability of information to any authorized user anywhere within the enterprise.
For additional details, visit www.urmc.rochester.edu/pacs2005.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.